Zavie, I don't know what LOG REDUCTION is or how it effects our Leukemia!  
Could you explain it!  I'm probably not the only one that needs this 
knowledge.  Jim Rodeghier

--- On Tue, 10/20/09, Zavie Miller <[email protected]> wrote:


From: Zavie Miller <[email protected]>
Subject: [CMLHope] Novartis drug TasignaR meets primary endpoint in pivotal 
trial against GlivecR as first-line treatment in chronic myeloid leukemia 
patients
To: [email protected], [email protected]
Date: Tuesday, October 20, 2009, 11:40 PM








 

http://www.pipelinereview.com/index.php/2009102030206/Small-Molecules/Novartis-drug-Tasigna-meets-primary-endpoint-in-pivotal-trial-against-Glivec-as-first-line-treatment-in-chronic-myeloid-leukemia-patients.html
 
 
 
Zavie Miller (age 71)
67 Shoreham Avenue
Ottawa, Canada, K2G 3X3
dxd AUG/99
INF OCT/99 to FEB/00, CHF
No meds FEB/00 to JAN/01
Gleevec since MAR/27/01 (400 mg)
CCR SEP/01. #102 in Zero Club
2.8 log reduction Sep/05
3.0 log reduction Jan/06
2.9 log reduction Feb/07
3.6 log reduction Apr/08
3.6 log reduction Sep/08
3.7 log reduction Jan/09
3.8 log reduction May/09
3.8 log reduction Aug/09
e-mail: [email protected]
Tel: 613-726-1117
Fax: 613-482-4801
Cell: 613-282-0204
Yahoo ID: zaviem
 


--~--~---------~--~----~------------~-------~--~----~
[CMLHope]
A support group of http://cmlhope.com
-------------------------------------------------

You received this message because you are subscribed to the Google Groups 
"CMLHope" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to 
[email protected]
For more options, visit this group at http://groups.google.com/group/CMLHope
-~----------~----~----~----~------~----~------~--~---

Reply via email to